{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:33:54Z","timestamp":1791599634430,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"am","delay-in-days":272,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["F31DA057832"],"award-info":[{"award-number":["F31DA057832"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["AQ-0039"],"award-info":[{"award-number":["AQ-0039"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuropharm.2025.110601","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T23:00:25Z","timestamp":1753484425000},"page":"110601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Comparison of ventilatory depression by carfentanil, fentanyl, and heroin, and reversal by opioid receptor antagonists in rats"],"prefix":"10.1016","volume":"279","author":[{"given":"Shawn M.","family":"Flynn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5157-6307","authenticated-orcid":false,"given":"Charles P.","family":"France","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110601_bib1","series-title":"Provisional Drug Overdose Death Counts","author":"Ahmad","year":"2024"},{"key":"10.1016\/j.neuropharm.2025.110601_bib2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/bph.17376","article-title":"Slow dissociation kinetics of fentanyls and nitazenes correlates with reduced sensitivity to naloxone reversal at the \u03bc-opioid receptor","volume":"182","author":"Alhosan","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110601_bib3","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1021\/acschemneuro.4c00203","article-title":"Structure-activity relationships of the fentanyl scaffold: identification of antagonists as potential opioid overdose reversal agents","volume":"15","author":"Anand","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110601_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1476-5381.1959.tb00928.x","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.neuropharm.2025.110601_bib5","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/ajhp\/zxz208","article-title":"Higher naloxone dosing May be required for opioid overdose","volume":"76","author":"Bardsley","year":"2019","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.neuropharm.2025.110601_bib6","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00213-022-06125-5","article-title":"Treatment of opioid overdose: current approaches and recent advances","volume":"239","author":"Britch","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110601_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/nyas.14349","article-title":"Designer drugs: a medicinal chemistry perspective (II)","volume":"1489","author":"Carroll","year":"2021","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2025.110601_bib8","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.ajem.2017.08.045","article-title":"Controversies and carfentanil: we have much to learn about the present state of opioid poisoning","volume":"35","author":"Cole","year":"2017","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2025.110601_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1021\/acsptsci.1c00260","article-title":"Efficacy and selectivity of monovalent and bivalent vaccination strategies to protect against exposure to carfentanil, fentanyl, and their mixtures in rats","volume":"5","author":"Crouse","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.neuropharm.2025.110601_bib10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00000542-199804000-00009","article-title":"Sex-related differences in the influence of morphine on ventilatory control in humans","volume":"88","author":"Dahan","year":"1998","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2025.110601_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15585\/mmwr.mm6905a2","article-title":"Carfentanil outbreak \u2014 florida, 2016\u20132017","volume":"69","author":"Delcher","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.neuropharm.2025.110601_bib12","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1007\/s00204-025-04048-6","article-title":"Carfentanil stabilizes \u03bc opioid receptor conformations that are ultra-efficient in inhibiting cAMP, resistant to naloxone or nalmefene but sensitive to naltrexone","volume":"99","author":"Endt","year":"2025","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110601_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1359851","article-title":"Are carfentanil and acrylfentanyl naloxone resistant?","volume":"15","author":"Feasel","year":"2024","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110601_bib14","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.toxac.2022.06.039","article-title":"Massive intoxication due to cocaine adulterated with carfentanil","volume":"34","author":"Ferrari","year":"2022","journal-title":"Toxicologie Analytique et Clinique"},{"key":"10.1016\/j.neuropharm.2025.110601_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108599","article-title":"Discriminative stimulus effects of carfentanil in rats discriminating fentanyl: differential antagonism by naltrexone","volume":"221","author":"Flynn","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110601_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/jpet.121.000912","article-title":"Characterization of the discriminative stimulus effects of binary mixtures of Mu opioid receptor agonists in rats discriminating fentanyl","volume":"380","author":"Flynn","year":"2022","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110601_bib17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1021\/acsptsci.2c00230","article-title":"Effects of gabapentinoids on heroin-induced ventilatory depression and reversal by naloxone","volume":"6","author":"Flynn","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.neuropharm.2025.110601_bib18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0022-3565(25)21704-9","article-title":"Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine","volume":"230","author":"France","year":"1984","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110601_bib19","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1017\/S1461145714000169","article-title":"Role of 6-monoacetylmorphine in the acute release of striatal dopamine induced by intravenous heroin","volume":"17","author":"Gott\u00e5s","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110601_bib20","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/ALN.0000000000003156","article-title":"Severe hypoxemia prevents spontaneous and naloxone-induced breathing recovery after fentanyl overdose in awake and sedated rats","volume":"132","author":"Haouzi","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2025.110601_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103457","article-title":"Increasingly powerful opioid antagonists are not necessary","volume":"99","author":"Hill","year":"2022","journal-title":"Int. J. Drug Pol."},{"key":"10.1016\/j.neuropharm.2025.110601_bib22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bph.14860","article-title":"Fentanyl depression of respiration: Comparison with heroin and morphine","volume":"177","author":"Hill","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110601_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1124\/jpet.123.002032","article-title":"Comparison of the \u03bc-Opioid receptor antagonists methocinnamox and naloxone to reverse and prevent the ventilatory depressant effects of fentanyl, carfentanil, 3-Methylfentanyl, and heroin in Male rats","volume":"391","author":"Hiranita","year":"2024","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110601_bib24","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1038\/s41598-022-09601-2","article-title":"Naloxone's dose-dependent displacement of [11c]carfentanil and duration of receptor occupancy in the rat brain","volume":"12","author":"Kang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110601_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1399803","article-title":"Comparison of intranasal naloxone and intranasal nalmefene in a translational model assessing the impact of synthetic opioid overdose on respiratory depression and cardiac arrest","volume":"15","author":"Laffont","year":"2024","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110601_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109427","article-title":"Variability in the unregulated opioid market in the context of extreme rates of overdose","volume":"235","author":"Larnder","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110601_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12954-024-00994-z","article-title":"High-dose naloxone formulations are not as essential as we thought","volume":"21","author":"Lemen","year":"2024","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.neuropharm.2025.110601_bib28","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1021\/acsptsci.3c00031","article-title":"Catalytic antibody blunts carfentanil-induced respiratory depression","volume":"6","author":"Lin","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.neuropharm.2025.110601_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jpainsymman.2005.01.012","article-title":"Pharmacokinetic\u2013pharmacodynamic modeling of opioids","volume":"29","author":"L\u00f6tsch","year":"2005","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.neuropharm.2025.110601_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-2999(92)90685-W","article-title":"Pharmacological profiles of fentanyl analogs at \u03bc, \u03b4 and \u03ba opiate receptors","volume":"213","author":"Maguire","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110601_bib31","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/cpt.2696","article-title":"Development of a translational model to assess the impact of opioid overdose and naloxone dosing on respiratory depression and cardiac arrest","volume":"112","author":"Mann","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2025.110601_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/jpet.122.001476","article-title":"Heroin- and fentanyl-induced respiratory depression in a rat plethysmography model: potency, tolerance, and sex differences","volume":"385","author":"Marchette","year":"2023","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110601_bib33","first-page":"313","article-title":"Comparison between epidural fentanyl, sufentanil, carfentanil, lofentanil and alfentanil in the rat: Analgesia and other in vivo effects","volume":"5","author":"Meert","year":"1988","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.neuropharm.2025.110601_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108974","article-title":"Fentanyl causes naloxone-resistant vocal cord closure: a platform for testing opioid overdose treatments","volume":"227","author":"Miner","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2025.110601_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13011-019-0195-4","article-title":"Higher doses of naloxone are needed in the synthetic opioid era","volume":"14","author":"Moss","year":"2019","journal-title":"Subst. Abuse Treat. Prev. Pol."},{"key":"10.1016\/j.neuropharm.2025.110601_bib36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.15585\/mmwr.mm6727a4","article-title":"Notes from the field: overdose deaths with carfentanil and other fentanyl analogs detected \u2014 10 states, July 2016\u2013June 2017","volume":"67","author":"O'Donnell","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.neuropharm.2025.110601_bib37","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/jat\/bkx068","article-title":"Observed carfentanil concentrations in 355 blood specimens from forensic investigations","volume":"41","author":"Papsun","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110601_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/2042098617744161","article-title":"Naloxone dosage for opioid reversal: current evidence and clinical implications","volume":"9","author":"Rzasa Lynn","year":"2018","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.neuropharm.2025.110601_bib39","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00000542-199905000-00017","article-title":"Sex differences in morphine-induced ventilatory depression reside within the peripheral chemoreflex loop","volume":"90","author":"Sarton","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2025.110601_bib40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0031-6997(25)07223-0","article-title":"Drug antagonism and pAx","volume":"9","author":"Schild","year":"1957","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110601_bib41","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/jat\/bkx042","article-title":"Detection of carfentanil by LC\u2013MS-MS and reports of associated fatalities in the USA","volume":"41","author":"Shanks","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.neuropharm.2025.110601_bib42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0033354919887741","article-title":"The emerging role of toxic adulterants in street drugs in the US illicit opioid crisis","volume":"135","author":"Singh","year":"2019","journal-title":"Publ. Health Rep."},{"key":"10.1016\/j.neuropharm.2025.110601_bib43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/acem.13034","article-title":"Fatal fentanyl: one pill can kill","volume":"24","author":"Sutter","year":"2017","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2025.110601_bib44","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.15585\/mmwr.mm7348a2","article-title":"Detection of illegally manufactured fentanyls and carfentanil in drug overdose deaths \u2014 united States, 2021\u20132024","volume":"73","author":"Tanz","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.neuropharm.2025.110601_bib45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10822-005-8694-y","article-title":"Virtual computational chemistry laboratory--design and description","volume":"19","author":"Tetko","year":"2005","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.neuropharm.2025.110601_bib46","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0026-895X(25)15170-5","article-title":"Etorphine binds to multiple opiate receptors of the caudate nucleus with equal affinity but with different kinetics","volume":"22","author":"Tolkovsky","year":"1982","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110601_bib47","first-page":"1548","article-title":"N-4-Substituted 1-(2-arylethyl)-4-piperidinyl-N-phenylpropanamides, a novel series of extremely potent analgesics with unusually high safety margin","volume":"26","author":"Van Bever","year":"1976","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.neuropharm.2025.110601_bib48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0022-3565(25)25802-5","article-title":"The pharmacologic effects of heroin in relationship to its rate of biotransformation","volume":"129","author":"Way","year":"1960","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2025.110601_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13265","article-title":"Assessment of abuse potential of carfentanil","volume":"28","author":"Wei","year":"2023","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2025.110601_bib50","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1152\/japplphysiol.90802.2008","article-title":"Hypoxic and hypercapnic ventilatory responses in aging Male vs. aging female rats","volume":"106","author":"Wenninger","year":"2009","journal-title":"J. Appl. Physiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:16:40Z","timestamp":1780028200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825003090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":50,"alternative-id":["S0028390825003090"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110601","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of ventilatory depression by carfentanil, fentanyl, and heroin, and reversal by opioid receptor antagonists in rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110601"}}